DHHS (NIOSH) Publication No. 2001-115

 

Also available in PDF format (538K - 16 pages).

Ordering Information


To receive documents or other information about occupational safety and health topics,
contact the National Institute for Occupational Safety and Health (NIOSH) at

NIOSH—Publications Dissemination
4676 Columbia Parkway
Cincinnati, OH 45226–1998

Telephone: 1–800–35–NIOSH (1–800–356–4674)
Fax number: 513–533–8573
E-mail: pubstaft@cdc.gov

or visit the NIOSH Web site at www.cdc.gov/niosh

This document is in the public domain and may be freely copied or reprinted.

Disclaimer: Mention of any company or product does not constitute endorsement by NIOSH.


Contents

Introduction
What health effects can exposure to glutaraldehyde cause?
Who might be exposed to glutaraldehyde in hospitals?
When are workers most likely to be exposed to glutaraldehyde in hospitals?
How can I protect myself from exposure to glutaraldehyde?
Safety Tips
Case Report
More information about glutaraldehyde

GLUTARALDEHYDE

Introduction

lutaraldehyde is used as a cold sterilant to disinfect and clean heat-sensitive equipment such as dialysis instruments, surgical instruments, suction bottles, bronchoscopes, endoscopes, and ear, nose, and throat instruments. This chemical is also used as a tissue fixative in histology and pathology labs and as a hardening agent in the development of x-rays. Glutaraldehyde is a colorless, oily liquid with a pungent odor. Hospital workers use it most often in a diluted form mixed with water. The strength of glutaraldehyde and water solutions typically ranges from 1% to 50%, but other formulations are available. Trade names include Cidex®, Sonacide®, Sporicidin®, Hospex®, Omnicide®, Metricide®, and Wavicide®.

The purpose of this brochure is to

—make you aware of the adverse health effects of glutaraldehyde,

—describe how you can be exposed to glutaraldehyde, and

—provide and identify control methods and work practices to prevent or reduce your exposure to glutaraldehyde.

What health effects can exposure to glutaraldehyde cause?

The following health effects have been reported in hospital workers exposed to glutaraldehyde:

If you experience any of these symptoms when working with glutaraldehyde, report them to your supervisor or safety officer.

Who might be exposed to glutaraldehyde in hospitals?

Workers in hospitals who might be exposed to glutaraldehyde include the following:

When are workers most likely to be exposed to glutaraldehyde in hospitals?

Workers can be exposed to glutaraldehyde by breathing it or by skin contact during the following procedures:

X-ray development imagemicroscope image

How can I protect myself from exposure to glutaraldehyde?

You can protect yourself by using the following control methods and work practices:

Safety Tips

CASE REPORT——Several nurses were working in an area where glutaraldehyde was stored in 1-liter baths on countertops and was used to disinfect bronchoscopes. They complained of hives, chest tightness, and watery eyes. Evaluation of the work area indicated that there was a separate (independent) recirculating ventilation system designed to provide 10% outside air. The nurses used no personal protective equipment (such as gloves). Measures were then taken to reduce exposures. These included changing glutaraldehyde containers to air-tight models, using appropriate gloves, and installing local ventilation hoods for glutaraldehyde stations. One month after the implementation of these measures, the nurses' symptoms subsided [Charney 1991].

More information about glutaraldehyde

ANSI/AAMI [1996]. American national standard: safe use and handling of glutaraldehyde-based products in health care facilities. Arlington, VA: American National Standards Institute, Inc., and Association for the Advancement of Medical Instrumentation, ANSI/AAMI ST58–1996.

Babb JR, Bradley CR [1995]. Endoscope decontamination: where do we go from here? J Hosp Infect 30(Suppl):543–551.

Ballantyne B, Berman B [1984]. Dermal sensitizing potential of glutaraldehyde: a review and recent observations. J Toxicol Cutaneous Ocul Toxicol 3:251–262.

Beauchamp RO Jr., St. Clair MBG, Fennell TR, Clarke DO, Morgan KT [1992]. A critical review of the toxicology of glutaraldehyde. Crit Rev Toxicol 22(3,4):143–174.

Butt G, Greenley P, Herrick R, DiBerardinis L [1999]. Exposure to glutaraldehyde vapors during endoscopic sterilization processes in a large research and teaching institution. Infect Control 3(4):172–179.

Charney W [1991]. Hidden toxicities of glutaraldehyde. In: Charney W, Schirmer J, eds. Essentials of modern hospital safety. Chelsea, MI: Lewis Publishers, Inc., pp. 71–81.

Evans PF, Elliott-Minty C, Saleem A, Morris L, Groves J, Pedersen R [1997]. Glutaraldehyde: Criteria document for an occupational exposure limit. London, United Kingdom: Health and Safety Executive (HSE).

Finucane EW [1993]. Monitoring aldehydes in the hospital. In: Charney W, Schirmer J, eds. Essentials of modern hospital safety. Vol. 2. Boca Raton, FL: Lewis Publishers, Inc., pp. 191–210.

NIOSH [1997]. NIOSH pocket guide to chemical hazards. Cincinnati, OH: U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, DHHS (NIOSH) Publication No. 97–140.

Norbäck D [1988]. Skin and respiratory symptoms from exposure to alkaline glutaraldehyde in medical services. Scand J Work Environ Health 14:366–371.

Pisaniello DL, Gun RT, Tkaczuk MN, Nitshcke M, Crea J [1997]. Glutaraldehyde exposures and symptoms among endoscopy nurses in South Australia. Appl Occup Environ Hyg 12(3):171–177.

Scobbie E, Dabill DW, Groves JA [1996]. Chemical pollutants in x-ray film processing departments. Ann Occup Hyg 40(4):423–435.

Stenton SC, Beach JR, Dennis JH, Keaney NP, Hendrick DJ [1994]. Glutaraldehyde, asthma, and work—a cautionary tale. Occup Med 44(2):95–98.

Waterman L [1992]. The hazards of health care—glutaraldehyde: a review of its clinical use and abuse. The Safety & Health Practitioner, June, pp. 15–17.

back to top  

Department of Health and Human Services
Public Health Service
Centers for Disease Control and Prevention
National Institute for Occupational Safety and Health
4676 Columbia Parkway
Cincinnati, OH 45226–1998

_________________________
OFFICIAL BUSINESS
Penalty for private use $300

To receive NIOSH documents or more information
about occupational safety and health topics, contact
NIOSH at 1–800–35–NIOSH (1–800–356–4674)
Fax: (513) 533–8573 — E-mail: pubstaft@cdc.gov
or visit the NIOSH Web site at www.cdc.gov/niosh

DHHS (NIOSH) Publication No. 2001-115
September 2001